-
51.
公开(公告)号:BR112013011198A2
公开(公告)日:2016-07-05
申请号:BR112013011198
申请日:2011-11-04
Applicant: ACADEMIA SINICA
Inventor: MA CHE , WONG CHI-HUEY , TSENG YUNG-CHIEH
Abstract: métodos para produzir partículas virais com glicosilação simplificada de proteínas de superfície. os métodos para a produção de partículas de vírus com a glicosilação simplificada em proteínas estruturais ou de superfície são fornecidos. quando usados como alvos para a produção de vacinas, a natureza conservada de tais locais gera vacinas que são menos sensíveis às mutações virais. o uso de inibidores de glicosilação para a produção de vírus com perfis de glicosilação simplificados são divulgados. uma divulgação exemplar dos vírus influenza e métodos para a produção de partículas de vírus influenza monoglicosilado ser fornecido. os métodos para a produção de formas de monoglicosilado de vírus influenza a, nibrg-14 (h5n1) são fornecidos.
-
">
公开(公告)号:BRPI1012635A2
公开(公告)日:2016-06-21
申请号:BRPI1012635
申请日:2010-03-26
Applicant: ACADEMIA SINICA
Inventor: MA CHE , WANG CHI-CHENG , WONG CHI-HUEY , CHEN JUINE-RUEY
IPC: A61K39/12
-
公开(公告)号:AU2016203431A1
公开(公告)日:2016-06-16
申请号:AU2016203431
申请日:2016-05-25
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , MA CHE , WANG CHENG-CHI , CHEN JUINE-RUEY
IPC: A61K39/12
Abstract: METHODS AND COMPOSITIONS FOR IMMUNIZATION AGAINST Immunogenic compositions comprising partially glycosylated viral glycoproteins for use as vaccines against viruses are provided. Vaccines formulated using mono-, di-, or tri-glycosylated viral surface glycoproteins and polypeptides provide potent and broad protection against viruses, even across strains. Pharmaceutical compositions comprising monoglycosylated hemagglutinin polypeptides and vaccines generated therefrom and methods of their use for prophylaxis or treatment of viral infections are disclosed. Methods and compositions are disclosed for influenza virus HA, NA and M2, RSV proteins F, G and SH, Dengue virus glycoproteins M or E, hepatitis C virus glycoprotein El or E2 and HIV glycoproteins gp120 and gp4l.
-
公开(公告)号:DK2411528T3
公开(公告)日:2015-12-14
申请号:DK10756991
申请日:2010-03-29
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , WU CHUNG-YI , CHENG TING-JEN R , HSU CHE-HSIUNG
-
公开(公告)号:CA2950577A1
公开(公告)日:2015-12-03
申请号:CA2950577
申请日:2015-05-27
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , TSAI TSUNG-I
IPC: C12N9/24
Abstract: The present disclosure relates to an a-fucosidase having a-(1,2), a-(1,3), a-(1,4), and a-(1,6) fucosidase activity. The present disclosure also relates to the compositions comprising the a-fucosidase, and the methods of producing and using the a-fucosidase in cleaving a-(1,2), a-(1,3), a-(1,4), and/or a-(1,6)-linked fucoses in the glycoconjugates. Accordingly, the present invention provides the compositions and methods for the improved enzymatic hydrolysis of fucose in vitro. In particular, the present invention is useful for the efficient cleavage of core fucose in native glycoproteins without denaturation or functional deterioration of glycoproteins. The compositions and methods of the invention can facilitate the Fc glycoengineering of Fc fusion proteins or antibodies, such as therapeutic antibodies.
-
公开(公告)号:CA2950433A1
公开(公告)日:2015-12-03
申请号:CA2950433
申请日:2015-05-27
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , WU CHUNG-YI
IPC: A61K39/395
Abstract: The present disclosure relates to a novel class of anti-TNFa monoclonal antibodies or antigen binding fragments comprising a homogeneous population of anti-TNFa IgG molecules having the same N-glycan on each of Fc. The antibodies of the invention can be produced from anti-TNFa monoclonal antibodies by Fc glycoengineering. The glycoantibodies of the invention may have improved therapeutic values compared to the corresponding monoclonal antibodies that have not been glycoengineered.
-
公开(公告)号:MX2014012413A
公开(公告)日:2015-08-07
申请号:MX2014012413
申请日:2013-04-12
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , FANG JIM-MIN , LIU KUNG-CHENG , JAN JIA-TSRONG , CHENG YIH-SHYUN E , CHENG TING-JEN R
Abstract: Se describen novedosos fármacos anti-influenza bi-funcionales, de doble enfoque, formados mediante conjugación con agentes anti-inflamatorios. Fármacos ejemplares de acuerdo con la invención incluyen conjugados de zanamivir (ZA) que porta ácido cafeico (CA) ZA-7-CA (1), ZA-7-CA-amida (7) y ZA-7-Nap (43) para inhibición simultánea de neuraminidasa de virus de influenza y supresión de citosinas proinflamatorias. Se proporcionan métodos sintéticos para la preparación de estos fármacos conjugados anti-influenza mejorados. Los conjugados de ZA bifuncionales sintéticos actúan sinérgicamente hacia la protección de ratones infectados letalmente por virus de influenza H1N1 o H5N1. La eficacia de conjugados ZA-7-CA, ZA-7-CA-amida y ZA-7-Nap es mucho mayor que la terapia de combinación de ZA con agentes anti-inflamatorios.
-
公开(公告)号:BRPI0822472A2
公开(公告)日:2015-06-16
申请号:BRPI0822472
申请日:2008-05-29
Applicant: ACADEMIA SINICA
Inventor: HSIEH SHIE-LIANG , WONG CHI-HUEY , HSU TSUI-LING , CHEN SZU-TING
IPC: G01N33/53
-
公开(公告)号:AU2013245756A1
公开(公告)日:2014-11-06
申请号:AU2013245756
申请日:2013-04-12
Applicant: WONG CHI-HUEY , LIU KUNG-CHENG , FANG JIM-MIN , CHENG YIH SHYUN , JAN JIA-TSRONG , ACADEMIA SINICA , CHENG TING JEN
Inventor: WONG CHI-HUEY , FANG JIM-MIN , LIU KUNG-CHENG , JAN JIA-TSRONG , CHENG YIH-SHYUN E , CHENG TING-JEN R
Abstract: Novel dual-targeted, bifunctional anti-influenza drugs formed by conjugation with anti-inflammatory agents are disclosed. Exemplary drugs according to the invention include caffeic acid (CA)-bearing zanamivir (ZA) conjugates ZA-7-CA (1), ZA-7-CA-amide (7) and ZA-7-Nap (43) for simultaneous inhibition of influenza virus neuraminidase and suppression of proinflammatory cytokines. Synthetic methods for preparation of these enhanced anti- influenza conjugate drugs are provided. The synthetic bifunctional ZA conjugates act synergistically towards protection of mice lethally infected by H1N1 or H5N1 influenza viruses. The efficacy of ZA-7-CA, ZA-7-CA-amide and ZA-7-Nap conjugates is much greater than the combination therapy of ZA with anti-inflammatory agents.
-
公开(公告)号:CA2870335A1
公开(公告)日:2013-10-17
申请号:CA2870335
申请日:2013-04-12
Applicant: ACADEMIA SINICA , WONG CHI-HUEY , FANG JIM-MIN , LIU KUNG-CHENG , JAN JIA-TSRONG , CHENG YIH-SHYUN E , CHENG TING-JEN R
Inventor: WONG CHI-HUEY , FANG JIM-MIN , LIU KUNG-CHENG , JAN JIA-TSRONG , CHENG YIH-SHYUN E , CHENG TING-JEN R
Abstract: Novel dual-targeted, bifunctional anti-influenza drugs formed by conjugation with anti-inflammatory agents are disclosed. Exemplary drugs according to the invention include caffeic acid (CA)-bearing zanamivir (ZA) conjugates ZA-7-CA (1), ZA-7-CA-amide (7) and ZA-7-Nap (43) for simultaneous inhibition of influenza virus neuraminidase and suppression of proinflammatory cytokines. Synthetic methods for preparation of these enhanced anti- influenza conjugate drugs are provided. The synthetic bifunctional ZA conjugates act synergistically towards protection of mice lethally infected by H1N1 or H5N1 influenza viruses. The efficacy of ZA-7-CA, ZA-7-CA-amide and ZA-7-Nap conjugates is much greater than the combination therapy of ZA with anti-inflammatory agents.
-
-
-
-
-
-
-
-
-